GCG and Other metabolic disease: In conclusion, our results present a new mechanism for incretin-based therapies showing that they could act on deleterious cardiovascular effects induced by high fat feeding and may have important contributions on the interplay between neuro-cardiovascular dynamic controls through mitochondrial dysfunction associated to metabolic disorders.